Thomas Carroll

Yo, you gotta hear about Thomas Carroll. This guy’s the real deal in biotech startup land. So, he’s a Rhodes Scholar- super smart, super driven. Co-founded Cleancard in 2021 with Luca Springer, also a Rhodes Scholar, which already says a lot about their brains and hustle. They’re based in SF, and their thing? Making cancer detection as easy as taking a pregnancy test. No bullshit, just a quick urine test at home that tells you if you got cancer in around 30 minutes. Crazy, right?

Thomas isn’t just some startup guy; he’s legit a clinical cancer researcher. His thing is bioinformatics and designing better biomarker tests-basically, making sure we catch cancer early and accurately. He’s been in the trenches, working on real science, and now he’s jumping into the startup game to change the way we diagnose cancer forever. That’s a huge deal. Most folks talk, he builds. He took Cleancard through Y Combinator’s S23 batch in 2023- which is basically the gold standard for startups, showing he’s got what it takes to crush it.

What’s wild about Thomas is that he’s blending hardcore science with startup grit. He’s not just in tech-he’s about saving lives, making diagnostics accessible, and cutting through the bullshit. His process proves he’s got mad motivation-not just to innovate, but to actually make a real impact. The guy’s been deep in research, and now he’s jumping into startup chaos because he sees a huge gap and is dead set on fixing it, fast.

In short, Thomas Carroll is that rare combo of scientist and entrepreneur. He’s out here trying to change cancer detection with AI and synthetic biology, making it quick, easy, and at-home. No Cap, he’s one of those founders who’s not just talking about change- he’s actually doing it. And honestly, that’s why he’s so important.